IFM CONTINUA, INC.
Profile
Company Names
IFM CONTINUA, INC.
Addresses
855 BOYLSTON STREET, 11TH FLOOR, BOSTON, MA 02116
Phone Numbers
857-327-9903
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2019
State Incorporated:
DELAWARE
Total Amount Raised:
$350,001.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2019-11-25
$350,001.00
INDEFINITE
INDEFINITE
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
SHELLEY
CHU
DIRECTOR
KALIDEX PHARMACEUTICALS, INC.
| ABINGWORTH BIOVENTURES VII LP
| VENATORX PHARMACEUTICALS, INC.
| IFM QUATTRO, INC.
| IFM CINQUE, INC.
| IFM CONTINUA, INC.
| SCORPION THERAPEUTICS, INC.
| ENLAZA THERAPEUTICS, INC.
| ABATA THERAPEUTICS, INC.
| PROTEGO BIOPHARMA
| TRIANA BIOMEDICINES, INC.
| SEISMIC THERAPEUTIC, INC.
| ANTARES THERAPEUTICS, INC.
| PROTEGO BIOPHARMA, INC.
| ODYSSEY THERAPEUTICS, INC.
JEAN-FRANCOIS
FORMELA
DIRECTOR
ARCA BIOPHARMA, INC.
| RESOLVYX PHARMACEUTICALS, INC.
| HORIZON PHARMA, INC.
| ANNOVATION BIOPHARMA, INC.
| ARTEAUS THERAPEUTICS, LLC
| COSTIM PHARMACEUTICALS INC.
| CALORICS, INC.
| NAVITOR PHARMACEUTICALS, INC.
| INTELLIA THERAPEUTICS, INC.
| IFM THERAPEUTICS, INC.
| SPERO THERAPEUTICS, LLC
| ATLAS VENTURE FUND XI, L.P.
| IFM TRE, INC.
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| TRANSLATE BIO, INC.
| KORRO BIO, INC.
| IFM QUATTRO, INC.
| IFM CINQUE, INC.
| IFM CONTINUA, INC.
| ATLAS VENTURE FUND XII, L.P.
| SCORPION THERAPEUTICS, INC.
| SPERO THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| ATLAS VENTURE FUND XIII, L.P.
| AMAGMA, INC.
| IKENA ONCOLOGY, INC.
| ANTARES THERAPEUTICS, INC.
GARY
GLICK
EXECUTIVE OFFICER, DIRECTOR
JOHN
LEONARD
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
